News

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious and often silent ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...
Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...
A new study published in the New England Journal of Medicine reveals that medications widely used for diabetes and obesity ...
Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...
By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...